Investor Presentation Q1 2018

Investor Presentation First three months of 2018 Slide 85 Biopharm and other chronic areas LIAM CLEMENS Liam has haemophilia A USA changing diabetes® 1. Biopharm at a glance 86 2. Haemophilia a rare disease 87 3. Haemophilia market 88 4. NovoSevenⓇ 89 5. NovoEight® 6. RefixiaⓇ/RebinynⓇ 90 91 7. N8-GP 92 8. Growth Hormone market 93 9. Other chronic disease 95-96 novo nordisk

View entire presentation